Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Antonio Montes-Cano M, Espín B, Galera A, Valverde J, Girón FJ, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C. Comino I, et al. Among authors: crespo l. Am J Gastroenterol. 2016 Oct;111(10):1456-1465. doi: 10.1038/ajg.2016.439. Epub 2016 Sep 20. Am J Gastroenterol. 2016. PMID: 27644734 Free PMC article.
Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Montes-Cano MA, Espín B, Galera A, Valverde J, José Girón F, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C. Comino I, et al. Among authors: crespo l. Am J Gastroenterol. 2017 Jul;112(7):1208. doi: 10.1038/ajg.2017.110. Epub 2017 Apr 11. Am J Gastroenterol. 2017. PMID: 28397876
Gamma delta+ intraepithelial lymphocytes and coeliac lymphogram in a diagnostic approach to coeliac disease in patients with seronegative villous atrophy.
Fernández-Bañares F, Crespo L, Núñez C, López-Palacios N, Tristán E, Vivas S, Farrais S, Arau B, Vidal J, Roy G, Esteve M. Fernández-Bañares F, et al. Among authors: crespo l. Aliment Pharmacol Ther. 2020 Apr;51(7):699-705. doi: 10.1111/apt.15663. Epub 2020 Feb 12. Aliment Pharmacol Ther. 2020. PMID: 32048756
The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C, Crespo L, Lopez N, De Andrés A, Ríos León R, Santón A, Garriga M, Butz E, León F, Roy Ariño G. García-Hoz C, et al. Among authors: crespo l. Dig Dis. 2020;38(6):490-499. doi: 10.1159/000506305. Epub 2020 Feb 4. Dig Dis. 2020. PMID: 32015237
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.
Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators. Cellier C, et al. Among authors: crespo l. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4. Lancet Gastroenterol Hepatol. 2019. PMID: 31494097 Clinical Trial.
Noninvasive diagnosis of hypolactasia with 4-Galactosylxylose (Gaxilose): a multicentre, open-label, phase IIB-III nonrandomized trial.
Aragón JJ, Hermida C, Martínez-Costa OH, Sánchez V, Martín I, Sánchez JJ, Codoceo R, Cano JM, Cano A, Crespo L, Torres Y, García FJ, Fernández-Mayoralas A, Solera J, Martínez P. Aragón JJ, et al. Among authors: crespo l. J Clin Gastroenterol. 2014 Jan;48(1):29-36. doi: 10.1097/MCG.0b013e318297fb10. J Clin Gastroenterol. 2014. PMID: 23722657 Clinical Trial.
Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosis.
Monsalve-Hernando C, Crespo L, Ferreiro B, Martín V, Aldeguer X, Opio V, Fernández-Gil PL, Gaspar MJ, Romero E, Lara C, Santander C, Torrealba L, Savescu T, Hermida C. Monsalve-Hernando C, et al. Among authors: crespo l. Medicine (Baltimore). 2018 Nov;97(46):e13136. doi: 10.1097/MD.0000000000013136. Medicine (Baltimore). 2018. PMID: 30431582 Free PMC article. Clinical Trial.
[Pneumatosis intestinalis].
Senosiain C, Crespo L, Maroto M, García-Sánchez MC. Senosiain C, et al. Among authors: crespo l. Med Clin (Barc). 2014 May 20;142(10):e19. doi: 10.1016/j.medcli.2013.11.015. Epub 2014 Jan 20. Med Clin (Barc). 2014. PMID: 24456919 Spanish. No abstract available.
121 results